Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta alethine in Waldenstrom's macroglobulinemia
NCT00041379Phase 2Unknown
- Sponsor
- LifeTime Pharmaceuticals, Inc.
- Start
- Mar 2002
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beta-alanine in Waldenstrom macroglobulinemia (WM), sponsored by LifeTime Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
beta-alanine
03
Conditions
Waldenstrom macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00041379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041379.